What this call funds
Expected Outcome
Successful proposals under this topic should contribute to the objectives of the EU Carbon Removals and Carbon Farming Certification (CRCF) Regulation and the Clean Industrial Deal, allowing industrial operators to use a sustainable carbon source as feedstock. They should facilitate innovators to scale up promising solutions in scope of the Strategy for European Life Sciences and the Biotech Act, also supporting the implementation of the EU Startup and Scaleup Strategy as well as the EU strategy on research and technology infrastructure.
Project results are expected to contribute to all of the following expected outcomes:
- innovative and improved purification and conversion of gaseous carbon is developed and scaled up to provide feedstock for industrial processes promoting circularity and climate neutrality;
- advanced industries – applying life sciences technologies and biotechnology - contribute to the climate-neutrality objective.
Scope
Increasing industrial productivity and competitiveness should not entail unsustainable exploitation of resources. This makes the sustainable sourcing of non-virgin-fossil carbon (i.e., carbon from sustainable sourced biomass, gaseous carbon, waste) essential for European industries, especially considering the production of chemicals and materials.
Proposals should address the following activities:
- review the up-to-date progress of R&I in the use of life sciences-based technologies for Carbon Capture and Use (CCU) phases taking into account the capture of gaseous carbon - from any industrial emission and the atmosphere – and its purification and conversion into products. Provide an assessment of their technological readiness, strengths and weaknesses and their potential of carbon storage in products;
- develop and test innovative and effective life sciences-based technologies, either synthetic biology and/or living microorganisms, to concentrate, purify and convert gaseous carbon efficiently into suitable feedstock to produce products. Products in scope exclude food/feed and biofuels/syngas;
- perform a preliminary assessment of the environmental impacts, the social and economic viability and business case of the developed technologies, including their scalability and the identification of markets for their output bio-based products;
- demonstrate one or more technology(ies) among those developed and tested, with the highest environmental, economic and social sustainability;
- evaluate and disseminate the replication potential of the demonstrated solution(s), including technical and economic/financial recommendations for SMEs and industrial operators in general;
- assess the feasibility of establishing a spin-off to implement the results from the best technology(ies) demonstration.
In the review of up-to-date progress of R&I as in the first bullet point, international cooperation is encouraged, as well as in the development of innovative technologies and evaluation of their replication potential. Synergies with activities under Cluster 5 and the Circular Bio-based Europe (CBE) Joint Undertaking are encouraged.
Projects funded under this topic should collaborate, for example within the activities concerning the exploitation of the IP of the developed technologies and at least within the dissemination activities.
Technology Readiness Level - Technology readiness level expected from completed projects
Activities are expected to achieve TRL 6-7 by the end of the project – see General Annex B. Activities may start at any TRL.
Eligibility & conditions+
General conditions
1. Admissibility Conditions: Proposal page limit and layout
described in Annex A and Annex E of the Horizon Europe Work Programme General Annexes.
Proposal page limits and layout: described in Part B of the Application Form available in the Submission System.
2. Eligible Countries
described in Annex B of the Work Programme General Annexes.
A number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon Europe projects. See the information in the Horizon Europe Programme Guide.
3. Other Eligible Conditions
In line with the “restriction on control in innovation actions in critical technology areas” delineated in General Annex B of the General Annexes, entities established in an eligible country but which are directly or indirectly controlled by China or by a legal entity established in China are not eligible to participate in the action.
described in Annex B of the Work Programme General Annexes.
4. Financial and operational capacity and exclusion
described in Annex C of the Work Programme General Annexes.
5a. Evaluation and award: Award criteria, scoring and thresholds
are described in Annex D of the Work Programme General Annexes.
5b. Evaluation and award: Submission and evaluation processes
are described in Annex F of the Work Programme General Annexes and the Online Manual.
5c. Evaluation and award: Indicative timeline for evaluation and grant agreement
described in Annex F of the Work Programme General Annexes.
6. Legal and financial set-up of the grants
The granting authority may, up to 4 years after the end of the action, object to a transfer of ownership or to the exclusive licensing of results, as set out in the specific provision of Annex 5.
Eligible costs will take the form of a lump sum as defined in the Decision of 7 July 2021 authorising the use of lump sum contributions under the Horizon Europe Programme – the Framework Programme for Research and Innovation (2021-2027) – and in actions under the Research and Training Programme of the European Atomic Energy Community (2021-2025) [[This decision is available on the Funding and Tenders Portal, in the reference documents section for Horizon Europe, under ‘Simplified costs decisions’ or through this link: https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/guidance/ls-decision_he_en.pdf]].
described in Annex G of the Work Programme General Annexes.
Specific conditions
described in the [specific topic of the Work Programme]
Application and evaluation forms and model grant agreement (MGA):
Application form templates — the application form specific to this call is available in the Submission System
Standard application form (HE RIA, IA)
Evaluation form templates — will be used with the necessary adaptations
Standard evaluation form (HE RIA, IA) 
Guidance
HE Programme Guide 
Model Grant Agreements (MGA)
Lump Sum MGA 
Call-specific instructions 
Detailed budget table (HE LS) 
Guidance: "Lump sums - what do I need to know?"
Additional documents:
HE Main Work Programme 2026-2027 – 1. General Introduction
HE Main Work Programme 2026-2027 – 9. Food, Bioeconomy, Natural Resources, Agriculture and Environment
HE Main Work Programme 2026-2027 – 15. General Annexes
HE Programme Guide
HE Framework Programme 2021/695
HE Specific Programme Decision 2021/764
EU Financial Regulation 2024/2509
Decision authorising the use of lump sum contributions under the Horizon Europe Programme
Rules for Legal Entity Validation, LEAR Appointment and Financial Capacity Assessment
EU Grants AGA — Annotated Model Grant Agreement
Funding & Tenders Portal Online Manual 
Funding & Tenders Portal Terms and Conditions 
Funding & Tenders Portal Privacy Statement
Source: EU Funding & Tenders Portal · synced 2026-10-13